Adaptive evolution of Staphylococcus aureus in atopic dermatitis patients

A recent study highlights the importance of evaluating microbes’ mutations in understanding the contribution of microbes to complex diseases.

Study reveals previously unknown viruses that populate the healthy infant gut

The findings of a recent study offer new insights into the diversity of the human virome and provide a resource that may help future research into the viruses that populate…

Discovering Wellmicro: pioneering breakthroughs in microbiome analysis for human health

Andrea Castagnetti, Antonella Padella and Matteo Soverini tell us about the activities and innovations of Wellmicro, the Italian company specializing in microbiota testing.

Biocodex becomes the sole shareholder of TargEDys

The French family company has acquired 100% of TargEDys’ shares, to consolidate the group’s strong ambition in the Microbiome and accelerate TargEDys’ development globally.

Healthy humans do not have a common blood microbiota

The findings suggest that microbes can occasionally enter the bloodstream from other body sites without causing disease, but they do not support the idea of a common blood microbiota.

Centenarians have a youthful gut microbiota that may help support longevity

The findings suggest that longevity is associated with a specific microbiota signature that may have positive effects on older adults’ health by counteracting senescence or chronic diseases that generally accompany…

Postbiotics, from bench to bedside

An open discussion about definition, clinical trial design and fields of application of postbiotics with Maria Rescigno, Professor at Humanitas University of Milan.

A mother’s vaginal microbes don’t influence her baby’s gut microbiota

The findings of a recent study show that a mother’s vaginal microbiota does not affect infant gut microbiota composition and development.

Nosocomial infection risks in critical illness: the microbiota-immune metasystem connection

An altered metasystem linking the gut microbiota and systemic immune response could lead to impaired host defense and increased vulnerability to hospital-acquired infections in cases of severe illness.

Targeting gut microbiome for disease diagnosis and therapy

Francesco Peri, full professor at University of Milano-Bicocca, discussed the role of gut microbiome as new frontier for personalized medicine.

Subscribe to MicrobiomePost newsletter

Take full advantage of MicrobiomePost‘s features.

Scroll to Top